
Re:Cognition Health becomes first network of clinical trial sites to have achieved GCSA Accredited status
London and Maidenhead, United Kingdom, 21 February 2023 – Re:Cognition Health’s commercial clinical research operational processes have undergone a rigorous evidence-based assessment to achieve all seven GCSA […]